Delivery Order SPE2DX22D0010-SPE2D826FCS76
Award Date 1/26/26
Potential Completion Date 1/27/26
Potential Value $6.7K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,864.76 by the Defense Logistics Agency for Nucynta (tapentadol) 75 mg tablets in a quantity of 100 units. This firm fixed-price, non-set-aside contract was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,288.63 on July 25, 2025, for the supply of Nucynta Tabs 50mg under a firm fixed price contract. This non-set-aside award is funded by the Defense Logistics Agency's Medical Supply Chain and is scheduled for completion by July 28, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,833.38 to AmerisourceBergen Drug Corp for the supply of Nucynta 75 mg tablets (100 count) on January 12, 2026, with an ultimate completion date of January 13, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was performed at the contractor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. Nucynta (tapentadol) is an...
- The Defense Logistics Agency awarded a $2,080.08 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta 75 mg, a pain management pharmaceutical. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of December 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award represents a child delivery order under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,148.57 to AmerisourceBergen Drug Corp for the supply of Nucynta 75 mg tablets (100 count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This competitive award, which utilized firm fixed pricing with no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX, valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $2,450.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta (tapentadol) 50 mg, with a completion date of June 16, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters. The delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical supply framework with the federal government....
- The U.S. Department of Defense Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta Tabs 100mg, a pain management pharmaceutical. This non-competitive, firm fixed-price delivery order, valued at $12,170.27, was issued on December 1, 2025, with an ultimate completion date of December 2, 2025. The contract will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Department of Defense awarded AmerisourceBergen Drug Corp a delivery order valued at $15,356.01 for Nucynta ER (tapentadol) 100mg tablets on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitive award under the Defense Logistics Agency's Medical Supply Chain operations. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $8,112 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Nucynta (tapentadol) 100 mg on September 23, 2025, with completion scheduled for September 24, 2025. This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Nucynta (tapentadol) 50 mg tablets in quantities of 100 units. This firm fixed price delivery order, valued at $2,384.48, was competitively awarded without set-aside restrictions and is scheduled for completion by September 11, 2025. The award represents a child contract under AmerisourceBergen's larger...